Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis

BACKGROUND: This study aimed to investigate the predictive values of serum biomarkers including absolute eosinophil count (AEC), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) with respect to immune-related adverse events (irAEs) during anti-PD-1/PD-L1 inhibitor treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yan, Ma, Xiao, Wang, Jingting, Wu, Shanshan, Wang, Jing, Cao, Bangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331074/
https://www.ncbi.nlm.nih.gov/pubmed/35897018
http://dx.doi.org/10.1186/s12957-022-02695-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331074/
https://www.ncbi.nlm.nih.gov/pubmed/35897018
http://dx.doi.org/10.1186/s12957-022-02695-y

Ejemplares similares